VEON(VEON)
VEON
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $4.95B | $5.30B | $5.71B | $6.12B | $6.53B |
| Low | $4.94B | $5.21B | $5.68B | $6.01B | $6.42B |
| High | $4.96B | $5.38B | $5.75B | $6.21B | $6.63B |
| EBITDA Avg | $2.12B | $2.27B | $2.45B | $2.62B | $2.80B |
| Low | $2.12B | $2.23B | $2.44B | $2.58B | $2.75B |
| High | $2.12B | $2.30B | $2.46B | $2.66B | $2.84B |
| EBIT Avg | $1.29B | $1.38B | $1.49B | $1.60B | $1.71B |
| Low | $1.29B | $1.36B | $1.48B | $1.57B | $1.68B |
| High | $1.29B | $1.40B | $1.50B | $1.62B | $1.73B |
| Net Income Avg | $508M | $667M | $822M | $1.02B | $1.35B |
| Low | $469M | $652M | $721M | $993M | $1.32B |
| High | $517M | $681M | $923M | $1.04B | $1.38B |
| EPS Avg | $6.87 | $9.31 | $11.70 | $14.17 | $18.86 |
| Low | $6.54 | $9.09 | $10.05 | $13.84 | $18.42 |
| High | $7.20 | $9.49 | $12.86 | $14.44 | $19.22 |
| Analysts (Rev / EPS) | 5 / 3 | 4 / 3 | 4 / 3 | 3 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $1.26B | $1.28B |
| Low | $1.26B | $1.27B |
| High | $1.27B | $1.29B |
| EBITDA Avg | $541M | $547M |
| Low | $538M | $545M |
| High | $544M | $551M |
| EBIT Avg | $330M | $334M |
| Low | $328M | $332M |
| High | $332M | $336M |
| Net Income Avg | $127M | $140M |
| Low | $126M | $139M |
| High | $128M | $142M |
| EPS Avg | $1.77 | $1.97 |
| Low | $1.76 | $1.95 |
| High | $1.79 | $1.98 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 |